Related Experiment Videos
ISBT 128 blood labeling: introduction and reference laboratory applications.
1Blood Bank and Transfusion Service, Ann Arbor, MI 48109, USA.
Immunohematology
|March 28, 2006
Summary
The ISBT 128 standard will soon be implemented in the US, enhancing blood product traceability and data accuracy. This system uses data identifiers and check characters to prevent errors and verify special testing results on labels.
Area of Science:
- Healthcare Information Technology
- Blood Transfusion Services
- Medical Laboratory Science
Background:
- The United States currently lacks a unified standard for blood product information.
- Existing systems face challenges in unit traceability and error detection during data entry.
- Accurate encoding of special testing results (e.g., CMV, RBC phenotype) is crucial for patient safety.
Purpose of the Study:
- To introduce the implementation of the ISBT 128 standard in the United States.
- To highlight the benefits of ISBT 128 for improving blood product management and data integrity.
- To outline the capabilities of ISBT 128 in error detection and verification of laboratory test results.
Main Methods:
- The study focuses on the upcoming adoption of the ISBT 128 standard.
- It describes the functionalities of ISBT 128, including data identifiers and check characters for error prevention.
- It also details the standard's capability to encode special testing results on labels.
Main Results:
- ISBT 128 implementation will improve unit traceability and lookback tracking.
- The standard's data identifiers and check characters will detect and prevent data entry errors.
- Laboratories will gain a computerized method to verify the accuracy of special testing results on labels.
Conclusions:
- The adoption of ISBT 128 in the US is a significant advancement for blood product safety and management.
- This information technology standard offers robust mechanisms for error detection and data verification.
- ISBT 128 will enhance the accuracy and reliability of critical information associated with blood products.